Skip to main content
. 2019 Jan 24;12:815–823. doi: 10.2147/OTT.S165647

Figure 1.

Figure 1

Expression of AKR1C1 in OS specimens.

Notes: (A) Negative staining of AKR1C1 in noncancerous tissues. (B) High expression of AKR1C1 in OS. (C) Weak expression of AKR1C1 in OS. (D) Negative expression of AKR1C1 in OS. IHC, ×200. (E) Patients with AKR1C expression had a shorter overall survival than those without AKR1C expression (negative vs positive: 43 vs 10 months; P=0.001).

Abbreviations: IHC, immunohistochemistry; OS, osteosarcoma.